Johns Hopkins Diabetes Guide

Acromegaly

Nestoras Mathioudakis, M.D.; Douglas Ball, M.D.

DEFINITION

  • A clinical syndrome resulting from excessive secretion of growth hormone (GH).
  • GH excess prior to closure of the epiphyseal plates results in gigantism; after epiphyseal plate closure, the result is acromegaly.
  • Somatic and metabolic effects of chronic GH hypersecretion are predominantly mediated by high levels of insulin-like growth factor-1 (IGF-1).
  • Acromegaly is an uncommon secondary cause of diabetes.
  • Excess GH: 1) stimulates gluconeogenesis and lipolysis, causing hyperglycemia and elevated free fatty acid levels; 2) leads to both hepatic and peripheral insulin resistance, with compensatory hyperinsulinemia. Conversely, IGF-1 increases insulin sensitivity. However, in acromegaly, increased IGF-1 levels are unable to overcome the insulin-resistant state caused by GH excess.

Acromegaly was found in Johns Hopkins Diabetes Guide.

If you are a registered user, please log in below.

If not, learn more about gaining full access.

Login

Forgot your password?

Forgot your username?

Try
Johns Hopkins Guides include up-to-date, authoritative content to help you treat patients and raise the standard of care.

Try these free topics now!

Johns Hopkins ABX Guide

Johns Hopkins Diabetes Guide

Johns Hopkins HIV Guide

Content Manager
Related Content
Hyperosmolar Hyperglycemic State